Literature DB >> 19684305

Neuropsychiatric manifestations in late-onset urea cycle disorder patients.

Mercedes Serrano1, Cecilia Martins, Belén Pérez-Dueñas, Lilian Gómez-López, Empar Murgui, Carmen Fons, Angels García-Cazorla, Rafael Artuch, Fernando Jara, José A Arranz, Johannes Häberle, Paz Briones, Jaume Campistol, Mercedes Pineda, Maria A Vilaseca.   

Abstract

Inherited urea cycle disorders represent one of the most common groups of inborn errors of metabolism. Late-onset urea cycle disorders caused by partial enzyme deficiencies may present with unexpected clinical phenotypes. We report 9 patients followed up in our hospital presenting late-onset urea cycle disorders who initially manifested neuropsychiatric/neurodevelopmental symptoms (the most prevalent neuropsychiatric/neurodevelopmental diagnoses were mental retardation, attention-deficit hyperactivity disorder [ADHD], language disorder, and delirium). Generally, these clinical pictures did not benefit from pharmacological treatment. Conversely, dietary treatment improved the symptoms. Regarding biochemical data, 2 patients showed normal ammonium but high glutamine levels. This study highlights the fact that neuropsychiatric/neurodevelopmental findings are common among the initial symptomatology of late-onset urea cycle disorders. The authors recommend that unexplained or nonresponsive neuropsychiatric/neurodevelopmental symptoms appearing during childhood or adolescence be followed by a study of ammonia and amino acid plasmatic levels to rule out a urea cycle disorder.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19684305     DOI: 10.1177/0883073809340696

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  10 in total

1.  The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype.

Authors:  Stefan Kölker; Vassili Valayannopoulos; Alberto B Burlina; Jolanta Sykut-Cegielska; Frits A Wijburg; Elisa Leão Teles; Jiri Zeman; Carlo Dionisi-Vici; Ivo Barić; Daniela Karall; Jean-Baptiste Arnoux; Paula Avram; Matthias R Baumgartner; Javier Blasco-Alonso; S P Nikolas Boy; Marlene Bøgehus Rasmussen; Peter Burgard; Brigitte Chabrol; Anupam Chakrapani; Kimberly Chapman; Elisenda Cortès I Saladelafont; Maria L Couce; Linda de Meirleir; Dries Dobbelaere; Francesca Furlan; Florian Gleich; Maria Julieta González; Wanda Gradowska; Stephanie Grünewald; Tomas Honzik; Friederike Hörster; Hariklea Ioannou; Anil Jalan; Johannes Häberle; Gisela Haege; Eveline Langereis; Pascale de Lonlay; Diego Martinelli; Shirou Matsumoto; Chris Mühlhausen; Elaine Murphy; Hélène Ogier de Baulny; Carlos Ortez; Consuelo C Pedrón; Guillem Pintos-Morell; Luis Pena-Quintana; Danijela Petković Ramadža; Esmeralda Rodrigues; Sabine Scholl-Bürgi; Etienne Sokal; Marshall L Summar; Nicholas Thompson; Roshni Vara; Inmaculada Vives Pinera; John H Walter; Monique Williams; Allan M Lund; Angeles Garcia-Cazorla; Angeles Garcia Cazorla
Journal:  J Inherit Metab Dis       Date:  2015-04-15       Impact factor: 4.982

2.  Behavioural and emotional problems, intellectual impairment and health-related quality of life in patients with organic acidurias and urea cycle disorders.

Authors:  Dagmar Jamiolkowski; Stefan Kölker; Esther M Glahn; Ivo Barić; Jiri Zeman; Matthias R Baumgartner; Chris Mühlhausen; Angels Garcia-Cazorla; Florian Gleich; Gisela Haege; Peter Burgard
Journal:  J Inherit Metab Dis       Date:  2015-08-27       Impact factor: 4.982

3.  Nonhepatic hyperammonemic encephalopathy due to undiagnosed urea cycle disorder.

Authors:  Tashfeen Mahmood; Kenneth Nugent
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-07

Review 4.  Recommendations for the Diagnosis and Therapeutic Management of Hyperammonaemia in Paediatric and Adult Patients.

Authors:  Amaya Bélanger-Quintana; Francisco Arrieta Blanco; Delia Barrio-Carreras; Ana Bergua Martínez; Elvira Cañedo Villarroya; María Teresa García-Silva; Rosa Lama More; Elena Martín-Hernández; Ana Moráis López; Montserrat Morales-Conejo; Consuelo Pedrón-Giner; Pilar Quijada-Fraile; Sinziana Stanescu; Mercedes Martínez-Pardo Casanova
Journal:  Nutrients       Date:  2022-07-02       Impact factor: 6.706

5.  Hyperammonemia due to Adult-Onset N-Acetylglutamate Synthase Deficiency.

Authors:  Anne-Els van de Logt; Leo A J Kluijtmans; Marleen C D G Huigen; Mirian C H Janssen
Journal:  JIMD Rep       Date:  2016-05-05

Review 6.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

Review 7.  A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.

Authors:  Richard E Frye; Daniel Rossignol; Manuel F Casanova; Gregory L Brown; Victoria Martin; Stephen Edelson; Robert Coben; Jeffrey Lewine; John C Slattery; Chrystal Lau; Paul Hardy; S Hossein Fatemi; Timothy D Folsom; Derrick Macfabe; James B Adams
Journal:  Front Public Health       Date:  2013-09-13

8.  Psychiatric adult-onset of urea cycle disorders: A case-series.

Authors:  Adrien Bigot; Paul Brunault; Christian Lavigne; François Feillet; Sylvie Odent; Elsa Kaphan; Christel Thauvin; Vanessa Leguy; Pierre Broué; Michel C Tchan; François Maillot
Journal:  Mol Genet Metab Rep       Date:  2017-07-06

Review 9.  Neuropsychological attributes of urea cycle disorders: A systematic review of the literature.

Authors:  Susan E Waisbren; Arianna K Stefanatos; Teresa M Y Kok; Burcu Ozturk-Hismi
Journal:  J Inherit Metab Dis       Date:  2019-08-01       Impact factor: 4.982

10.  High prevalence of self-reported autism spectrum disorder in the Propionic Acidemia Registry.

Authors:  Maria L Cotrina; Sindy Ferreiras; Patricia Schneider
Journal:  JIMD Rep       Date:  2019-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.